Join
Live feed
·
PRReleasevia Quantisnow
Kyverna Therapeutics Inc. logo

Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune Diseases

ByQuantisnow·Wall Street's wire, on your screen.
KYTX· Kyverna Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KYTX (Kyverna Therapeutics Inc.) and more on Quantisnow.